ReproCELL Incorporated (FRA:6RC)

ReproCELL Statistics

Total Valuation

ReproCELL has a market cap or net worth of EUR 82.88 million. The enterprise value is 51.02 million.

Market Cap	82.88M
Enterprise Value	51.02M

Important Dates

The next estimated earnings date is Friday, February 6, 2026.

Earnings Date	Feb 6, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	94.69M
Shares Outstanding	n/a
Shares Change (YoY)	+6.47%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	4.44%
Owned by Institutions (%)	0.24%
Float	90.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.47
PB Ratio	1.66
P/TBV Ratio	1.66
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-31.75
EV / Sales	3.50
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-28.40

Financial Position

The company has a current ratio of 11.09

Current Ratio	11.09
Quick Ratio	10.29
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -3.20% and return on invested capital (ROIC) is -3.79%.

Return on Equity (ROE)	-3.20%
Return on Assets (ROA)	-3.51%
Return on Invested Capital (ROIC)	-3.79%
Return on Capital Employed (ROCE)	-6.02%
Revenue Per Employee	153,114
Profits Per Employee	-16,231
Employee Count	99
Asset Turnover	0.28
Inventory Turnover	4.49

Taxes

Income Tax	-322,516
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +48.54% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+48.54%
50-Day Moving Average	0.81
200-Day Moving Average	0.84
Relative Strength Index (RSI)	58.77
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ReproCELL had revenue of EUR 15.16 million and -1.61 million in losses. Loss per share was -0.02.

Revenue	15.16M
Gross Profit	7.65M
Operating Income	-3.04M
Pretax Income	-1.93M
Net Income	-1.61M
EBITDA	-2.68M
EBIT	-3.04M
Loss Per Share	-0.02

Balance Sheet

The company has 33.12 million in cash and n/a in debt, giving a net cash position of 33.12 million.

Cash & Cash Equivalents	33.12M
Total Debt	n/a
Net Cash	33.12M
Net Cash Per Share	n/a
Equity (Book Value)	49.96M
Book Value Per Share	0.53
Working Capital	34.33M

Cash Flow

In the last 12 months, operating cash flow was -1.18 million and capital expenditures -616,236, giving a free cash flow of -1.80 million.

Operating Cash Flow	-1.18M
Capital Expenditures	-616,236
Free Cash Flow	-1.80M
FCF Per Share	n/a

Margins

Gross margin is 50.49%, with operating and profit margins of -20.06% and -10.60%.

Gross Margin	50.49%
Operating Margin	-20.06%
Pretax Margin	-12.73%
Profit Margin	-10.60%
EBITDA Margin	-17.71%
EBIT Margin	-20.06%
FCF Margin	n/a

Dividends & Yields

ReproCELL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.47%
Shareholder Yield	-6.47%
Earnings Yield	-1.94%
FCF Yield	-2.17%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 28, 2013. It was a forward split with a ratio of 5.

Last Split Date	Aug 28, 2013
Split Type	Forward
Split Ratio	5

Scores

ReproCELL has an Altman Z-Score of 13.5 and a Piotroski F-Score of 2.

Altman Z-Score	13.5
Piotroski F-Score	2